We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+7.7%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$521M
AUM Growth
+$64M
Cap. Flow
+$31.7M
Cap. Flow %
6.08%
Top 10 Hldgs %
25.71%
Holding
256
New
50
Increased
81
Reduced
62
Closed
52

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$14.6M
2
MET icon
MetLife
MET
+$9.19M
3
WBA
Walgreens Boots Alliance
WBA
+$9.05M
4
C icon
Citigroup
C
+$8.2M
5
TGT icon
Target
TGT
+$7.95M

Sector Composition

Rank Sector Weight
1 Technology 17.67%
2 Financials 16%
3 Healthcare 11.72%
4 Industrials 8.96%
5 Consumer Discretionary 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KKD
101
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
$714K 0.14%
37,034
-3,509
-9% -$79.2K
TXMD icon
102
TherapeuticsMD
TXMD
$24M
$704K 0.14%
+2,704
New +$592K
PRO
103
DELISTED
PROS Holdings
PRO
$675K 0.13%
16,929
-100
-0.6% -$3.59K
BGC icon
104
BGC Group
BGC
$4.89B
$663K 0.13%
170,319
+43,417
+34% +$158K
AYR
105
DELISTED
Aircastle Ltd
AYR
$626K 0.12%
+32,665
New +$606K
GNRC icon
106
Generac Holdings
GNRC
$12.5B
$607K 0.12%
10,718
-145
-1% -$7.09K
FOE
107
DELISTED
Ferro Corporation
FOE
$602K 0.12%
46,933
-7,245
-13% -$88K
OLN icon
108
Olin
OLN
$2.12B
$590K 0.11%
20,436
-100
-0.5% -$2.48K
SVU
109
DELISTED
SUPERVALU Inc.
SVU
$583K 0.11%
11,419
+7,983
+232% +$394K
SGYP
110
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$575K 0.11%
103,487
-2,129
-2% -$9.18K
DXPE icon
111
DXP Enterprises
DXPE
$2.98B
$541K 0.1%
4,695
-2,038
-30% -$192K
TLPH icon
112
Talphera
TLPH
$74.2M
$521K 0.1%
2,303
-10
-0.4% -$1.74K
SIMG
113
DELISTED
SILICON IMAGE INC
SIMG
$515K 0.1%
83,709
+6,141
+8% +$33.1K
CMCO icon
114
Columbus McKinnon
CMCO
$584M
$503K 0.1%
18,546
-100
-0.5% -$2.61K
VSTM icon
115
Verastem
VSTM
$610M
$494K 0.09%
3,610
+657
+22% +$86.4K
CMRX
116
DELISTED
Chimerix, Inc.
CMRX
$490K 0.09%
+32,414
New +$517K
FARO
117
DELISTED
Faro Technologies
FARO
$489K 0.09%
8,381
-7,167
-46% -$356K
LABL
118
DELISTED
Multi-Color Corp
LABL
$485K 0.09%
12,842
+2,880
+29% +$104K
WT icon
119
WisdomTree
WT
$3.22B
$478K 0.09%
+26,995
New +$384K
CY
120
DELISTED
Cypress Semiconductor
CY
$476K 0.09%
45,372
+4,800
+12% +$45.5K
ZIXI
121
DELISTED
Zix Corporation
ZIXI
$469K 0.09%
102,772
-100
-0.1% -$450
WOR icon
122
Worthington Enterprises
WOR
$2.86B
$463K 0.09%
17,845
-162
-0.9% -$4.02K
KG
123
Kestrel Group
KG
$69M
$462K 0.09%
2,115
+287
+16% +$67.2K
AMP icon
124
Ameriprise Financial
AMP
$48.8B
$460K 0.09%
4,000
-29,993
-88% -$3.1M
BBRG
125
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
$460K 0.09%
28,251
-100
-0.4% -$1.55K

Similar funds

Stoneridge Investment Partners's Q4 2013 Portfolio in Review

As of Q4 2013, Stoneridge Investment Partners held 256 positions worth $521M, up 14% from $457M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Stoneridge Investment Partners deployed $31.7M of net new capital in Q4 2013, opening 50 new positions and adding to 81 existing holdings. Its largest new stake was Mondelez International: 285,413 shares worth $10.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Target, an estimated $7.95M trimmed.

  • Stoneridge Investment Partners's largest Q4 2013 buy was Mondelez International: 285,413 shares worth $10.1M.
  • Stoneridge Investment Partners added most to Twenty-First Century Fox, Inc. Class A in Q4 2013, an estimated $9.61M increase.
  • Stoneridge Investment Partners's biggest Q4 2013 reduction was Target, cutting an estimated $7.95M.
  • Stoneridge Investment Partners fully exited AbbVie in Q4 2013, selling an estimated $14.6M.
  • Stoneridge Investment Partners's ten largest holdings make up 26% of its $521M portfolio in Q4 2013.
  • Stoneridge Investment Partners opened 50 new positions and closed 52 in Q4 2013.
  • Stoneridge Investment Partners's portfolio value rose 14% quarter-over-quarter to $521M.

Based on Stoneridge Investment Partners's 13F filing for Q4 2013, filed 14 Jan 2014.